<p>BALB/c mice were immunized IN with RSV-virosomal vaccine formulations (5 µg of protein) or HNE. Control mouse groups were either immunized IM with FI-RSV or IN with L-RSV on day 0 and 21. Mice were challenged with live-RSV on day 28 and four days after challenge (day 32), lung viral titers were determined. Data from 6 mice per group is shown. Viral titers are expressed as TCID<sub>50</sub>. Bars and error bars represent means ± SD. The data shown are representative of at least 2 separate experiments. Data was analyzed by a Mann-Whitney U test and a p-value of ≤ 0.05 was considered to represent a significant difference. Asterisks indicate groups that had significantly lower viral titers compared to titers in the non-immune HNE group. Hori...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>WT C57BL/6 and OPN-/- mice were intranasally infection with a high dose of mucogenic rA2-L19F (1×...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes and control vaccines as in <a h...
(A) Schematic representation of mouse immunization and challenge schedule. BALB/c mice (N = 6 per gr...
<p>Mice (N = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>Lung viral titers were determined from mice immunized with V1 or V5 VLPs and from FI-RSV immunize...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes or controls (HNE, live virus an...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2, rested for at four weeks and i.n chal...
<p>BALB/c mice were immunized IN with RSV virosomal vaccine formulations (5 µg of protein) or HNE. C...
<p>(A) FI-mock- and FI-RSV-vaccinated mice were monitored daily for airway obstruction using a whole...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>Mice were vaccinated with NE-RSV or FI-RSV, as described, and challenged with live RSV. In (A), t...
Vaccinated and naïve mice (n = 5) were intranasally challenged with RSV A2 (5×105 PFU) at 3 weeks af...
<p>Mice were vaccinated as described in <a href="http://www.plosone.org/article/info:doi/10.1371/jou...
<p>BALB/c mice were immunized as described above. One week after the booster immunization, mice were...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>WT C57BL/6 and OPN-/- mice were intranasally infection with a high dose of mucogenic rA2-L19F (1×...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes and control vaccines as in <a h...
(A) Schematic representation of mouse immunization and challenge schedule. BALB/c mice (N = 6 per gr...
<p>Mice (N = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>Lung viral titers were determined from mice immunized with V1 or V5 VLPs and from FI-RSV immunize...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes or controls (HNE, live virus an...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2, rested for at four weeks and i.n chal...
<p>BALB/c mice were immunized IN with RSV virosomal vaccine formulations (5 µg of protein) or HNE. C...
<p>(A) FI-mock- and FI-RSV-vaccinated mice were monitored daily for airway obstruction using a whole...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>Mice were vaccinated with NE-RSV or FI-RSV, as described, and challenged with live RSV. In (A), t...
Vaccinated and naïve mice (n = 5) were intranasally challenged with RSV A2 (5×105 PFU) at 3 weeks af...
<p>Mice were vaccinated as described in <a href="http://www.plosone.org/article/info:doi/10.1371/jou...
<p>BALB/c mice were immunized as described above. One week after the booster immunization, mice were...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>WT C57BL/6 and OPN-/- mice were intranasally infection with a high dose of mucogenic rA2-L19F (1×...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes and control vaccines as in <a h...